These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11738759)

  • 1. Tetanus toxin fragment C-specific priming by intranasal infection with recombinant Bordetella pertussis.
    Reveneau N; Alonso S; Jacob-Dubuisson F; Mercenier A; Locht C
    Vaccine; 2001 Dec; 20(5-6):926-33. PubMed ID: 11738759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein.
    Boucher P; Sato H; Sato Y; Locht C
    Infect Immun; 1994 Feb; 62(2):449-56. PubMed ID: 7507893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immune responses in mice immunized with recombinant Mycobacterium bovis Bacillus Calmette-Guérin producing a pertussis toxin-tetanus toxin hybrid protein.
    Abomoelak B; Huygen K; Kremer L; Turneer M; Locht C
    Infect Immun; 1999 Oct; 67(10):5100-5. PubMed ID: 10496883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.
    Barry EM; Gomez-Duarte O; Chatfield S; Rappuoli R; Pizza M; Losonsky G; Galen J; Levine MM
    Infect Immun; 1996 Oct; 64(10):4172-81. PubMed ID: 8926085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations.
    Reveneau N; Geoffroy MC; Locht C; Chagnaud P; Mercenier A
    Vaccine; 2002 Mar; 20(13-14):1769-77. PubMed ID: 11906764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.
    Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
    Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
    Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
    Vaccine; 2001 Feb; 19(15-16):1931-9. PubMed ID: 11228363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sm14 of Schistosoma mansoni in fusion with tetanus toxin fragment C induces immunoprotection against tetanus and schistosomiasis in mice.
    Abreu PA; Miyasato PA; Vilar MM; Dias WO; Ho PL; Tendler M; Nascimento AL
    Infect Immun; 2004 Oct; 72(10):5931-7. PubMed ID: 15385496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of the genetically attenuated bacteria Bordetella pertussis devoid of dermonecrotic toxin activity and producing modified nontoxic pertussis toxin form].
    Siniashina LN; Siniashina LS; Semin EG; Amelina IP; Karataev GI
    Mol Gen Mikrobiol Virusol; 2010; (3):31-6. PubMed ID: 20886687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and delivery of tetanus toxin fragment C fused to the N-terminal domain of SipB enhances specific immune responses in mice.
    Jang JI; Kim JS; Eom JS; Kim HG; Kim BH; Lim S; Bang IS; Park YK
    Microbiol Immunol; 2012 Sep; 56(9):595-604. PubMed ID: 22708880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of Neisseria meningitidis transferrin-binding protein B by recombinant Bordetella pertussis.
    Coppens I; Alonso S; Antoine R; Jacob-Dubuisson F; Renauld-Mongénie G; Jacobs E; Locht C
    Infect Immun; 2001 Sep; 69(9):5440-6. PubMed ID: 11500415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.
    Robinson K; Chamberlain LM; Schofield KM; Wells JM; Le Page RW
    Nat Biotechnol; 1997 Jul; 15(7):653-7. PubMed ID: 9219268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.
    Robinson K; Chamberlain LM; Lopez MC; Rush CM; Marcotte H; Le Page RW; Wells JM
    Infect Immun; 2004 May; 72(5):2753-61. PubMed ID: 15102785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated Bordetella pertussis BPZE1 as a live vehicle for heterologous vaccine antigens delivery through the nasal route.
    Li R; Lim A; Alonso S
    Bioeng Bugs; 2011; 2(6):315-9. PubMed ID: 22067832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e.
    Kammoun H; Roux X; Raze D; Debrie AS; De Filette M; Ysenbaert T; Mielcarek N; Saelens X; Fiers W; Locht C
    PLoS One; 2013; 8(3):e59198. PubMed ID: 23555631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation.
    Mielcarek N; Debrie AS; Raze D; Quatannens J; Engle J; Goldman WE; Locht C
    Vaccine; 2006 Apr; 24 Suppl 2():S2-54-5. PubMed ID: 16823926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence.
    Grangette C; Müller-Alouf H; Geoffroy M; Goudercourt D; Turneer M; Mercenier A
    Vaccine; 2002 Sep; 20(27-28):3304-9. PubMed ID: 12213400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of live attenuated Bordetella pertussis strains expressing the universal influenza vaccine candidate M2e.
    Li R; Lim A; Ow ST; Phoon MC; Locht C; Chow VT; Alonso S
    Vaccine; 2011 Jul; 29(33):5502-11. PubMed ID: 21624415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a rationally attenuated Bordetella bronchiseptica as a live mucosal vaccine and vector for heterologous antigens.
    Stevenson A; Roberts M
    Vaccine; 2002 May; 20(17-18):2325-35. PubMed ID: 12009288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.